Montefiore Medical Center
Skip Navigation LinksClinical Looking Glass > The World of CLG > CLG in the News

CLG in the News

CLG in the News

A selection of recent news stories that demonstrate the uses and benefits of Clinical Looking Glass

NEW YORK – Montefiore Medical Center in New York’s Bronx borough has been providing quality care for decades, thanks to a clinical analytics system that could serve as a model for other healthcare systems across the country.  Called Clinical Looking Glass, or CLG, the technology is the brainchild of Eran Bellin, MD, vice president of clinical IT research and development at Montefiore.  Academic centers do critical research, but not without a programmer and researchers. The critical distinction with Montefiore’s technology is that it is readily accessible to doctors. It was built that way with the intention, said Bellin, to democratize the process.

Montefiore Medical Center, an academic medical center in New York City, has created an integrated system of care for its primarily low-income patients. This patient-centered system of hospitals, community clinics, and school-based clinics uses innovative practices for managing chronic disease, provides access to high-quality specialty hospital care, and employs targeted care management and robust health information technology in support of integrated care. Although close to 80 percent of its payer mix is Medicaid and Medicare, Montefiore has been able to achieve financial and organizational sustainability. Factors that contribute to this success include: care management that allows for integration across the system; building successful primary care that combines traditional and new models; and medical systems that focus on population health and community accountability.

Featured Story

At Montefiore Medical Center in Bronx, NY, researchers are harnessing the power of more than a decade's worth of electronic medical record data using a software program called Clinical Looking Glass (CLG). Developed by the academic medical center, the program interprets de-identified data for entire patient populations and can be used to gauge the effectiveness of patient safety measures, identify and track public health threats, and provide data for professional articles and published studies.

Clinical studies can take years to conduct. Just one example: A study of the widely used antibiotic gatifloxacin showed it could cause dangerous fluctuations in blood sugar levels among diabetic patients. After further research showed that all patients were at risk for the dangerous side effect, the drug was pulled from the market.